Vented UV Filter for Photostability Chamber Temperature Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current photostability testing methods overexpose drugs to ultraviolet light, leading to degradation and compromising the safety and efficacy of pharmaceutical products, while existing setups with separate UV and visible light sources are inefficient and resource-intensive.

Innovation Solution

A filter is introduced into the photostability testing chamber that limits UV light transmission, allowing simultaneous exposure to UV and visible light within regulatory requirements, maintaining controlled temperature through air circulation and using a single light source.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If a single light source emitting both UV and visible light is used for photostability testing, then testing efficiency is improved and resource consumption is reduced, but UV light overexposure occurs leading to drug degradation

Engineering Contradiction:
Improvetesting efficiencyVSAvoidUV light overexposure
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

A UV-filtering window is introduced as an intermediary component between the light source and the sample. This window selectively transmits visible light while blocking excessive UV light, allowing the single light source to be used efficiently without causing harmful UV overexposure to the drug sample.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The spectral parameters of the light transmission are modified by introducing a UV-filtering window. This changes the transmission characteristics to allow visible light passage while limiting UV light transmission, thereby resolving the contradiction between testing efficiency and UV overexposure prevention.

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If current ICH minimum requirements are followed with a single light source, then visible light exposure requirements are met, but UV light exposure is approximately 3 times overexposure

Engineering Contradiction:
Improvelight exposure controlVSAvoidUV light overexposure
Core Design Contradiction:
Manufacturing precisionVSObject-affected harmful factors

Solution Approach 1:

The UV-filtering window serves as a precision control intermediary that selectively filters UV wavelengths while transmitting visible light. This enables precise control of the light exposure parameters to meet ICH guidelines for visible light while preventing the 3-fold UV overexposure problem.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The filtering property is applied locally at the window interface where light enters the chamber. This local quality change (UV filtering) affects only the UV portion of the spectrum while leaving visible light transmission unchanged, achieving precise spectral control.

Inventive Principle:
Principle #3Local quality

3Reliability

If UV light transmission is reduced to prevent overexposure, then drug sample integrity is preserved, but light source efficiency may be reduced

Engineering Contradiction:
Improvedrug sample integrityVSAvoidlight source efficiency
Core Design Contradiction:
ReliabilityVSUse of energy by moving object

Solution Approach 1:

The UV-filtering window acts as a selective intermediary that preserves drug sample integrity by blocking excessive UV light while maintaining high efficiency in visible light transmission. The window is designed to minimize energy loss in the visible spectrum, thus preserving light source efficiency.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The transmission parameters are changed selectively across different wavelengths. UV transmission is reduced to protect sample integrity, while visible light transmission parameters are maintained to preserve light source efficiency and testing effectiveness.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The filter effectively reduces UV exposure by at least 30%, preserving the integrity and purity of drug samples, adhering to ICH Q1B guidelines without significant temperature changes, and ensuring consistent light application.

Implementation Method 1

the first planar structure comprises a polymer that limits at least 30% transmission of ultraviolet light

Methodology Applied
Scientific EffectAbsorption (EM radiation): Absorption (EM radiation)

Implementation Method 2

the first baffle of the filter is configured to direct air flow from the air inlet vent through the first through opening, across the first planar structure, and through the second through opening; and also below the filter into the sample area

Methodology Applied
Scientific EffectConvection: Convection

Data Source

PatentUS12529646B2Test chamber for photostability testing
Publication Date: 2026.01.20 LONZA AG
  • US12529646B2 patent drawing
  • US12529646B2 patent drawing
  • US12529646B2 patent drawing

AI summary

The present disclosure provides an ultraviolet light filter for use in photostability testing chambers, and in particular, filters that are designed to allow for air ventilation and maintenance of desired temperatures at the sample level during light exposure testing.